Previous Close | 20.69 |
Open | 20.46 |
Bid | 19.49 x 900 |
Ask | 20.61 x 3200 |
Day's Range | 19.45 - 20.73 |
52 Week Range | 15.50 - 24.75 |
Volume | |
Avg. Volume | 2,189,628 |
Market Cap | 6.167B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 38.22 |
EPS (TTM) | 0.51 |
Earnings Date | Feb 08, 2022 - Feb 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 27.17 |
The stock market continues to be under pressure due to geopolitical tensions and various economic problems. For instance, cancer-focused biotech company Exelixis (NASDAQ: EXEL) has run circles around the broader market year to date. Can Exelixis continue beating the market from here on out?
The stock market is highly volatile now. Robotic-assisted surgery is the future of surgery, and Intuitive Surgical (NASDAQ: ISRG) is already dominating the space. Biotech company Exelixis (NASDAQ: EXEL) and internet retail company Etsy (NASDAQ: ETSY) also have remarkable growth prospects that could bring in some exciting long-term returns.
With its stock down 11% over the past month, it is easy to disregard Exelixis (NASDAQ:EXEL). But if you pay close...